
News|Articles|September 1, 2026
Accelerating patient recruitment: Connecting the right patients to the right trial
Author(s)Quest Diagnostics
Advertisement
Discover how Quest Diagnostics puts its vast database of lab results to work and leverages patient and physician credibility to efficiently and effectively connect the best-fit patients to the clinical trials that will benefit from their participation.
This white paper is free and can be downloaded and read at your convenience.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Trump Administration Adds Nine Drugmakers to Most-Favored-Nation Program: Report
2
Eli Lilly to Acquire Merida Biosciences for $2.8 Billion
3
BioNTech Terminates Phase II Clinical Trial for Cevumeran
4
Pharmaceutical Executive Daily: Eli Lilly Enters $2.8 Billion Agreement to Acquire Merida Biosciences
5




